BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 17, Issue 22
This Article
Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
  • Total Article Views (6221)
All Articles published online
The chart showing PDF series, HTML series, Tables (1-2) series.
Item 
Count 
PDF592
HTML5380
Tables (1-2)249
 Sum=6221
Jun 14, 2011 (publication date) through Nov 27, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef
For: Román ALS, Muñoz F. Comorbidity in inflammatory bowel disease. World J Gastroenterol 2011; 17(22): 2723-2733 [PMID: 21734780 DOI: 10.3748/wjg.v17.i22.2723]
URL: https://www.wjgnet.com/1007-9327/full/v17/i22/2723.htm
Number Citing Articles
1
Hanna Öhlmann, Laura Ricarda Koenen, Franziska Labrenz, Harald Engler, Nina Theysohn, Jost Langhorst, Sigrid Elsenbruch. Altered Brain Structure in Chronic Visceral Pain: Specific Differences in Gray Matter Volume and Associations With Visceral Symptoms and Chronic Stress. Frontiers in Neurology 2021; 12 doi: 10.3389/fneur.2021.733035
2
Melania Dovizio, Susanne Hartz, Carlotta Buzzoni, Isabel Redondo, Marijana Nedeljkovic Protic, Domenico Birra, Valentina Perrone, Chiara Veronesi, Luca Degli Esposti, Alessandro Armuzzi. Real-World Treatment Patterns and Healthcare Resource Use for Ulcerative Colitis and Crohn’s Disease in Italy. Advances in Therapy 2024; 41(6): 2282 doi: 10.1007/s12325-024-02840-x
3
G. Conway, G. Velonias, E. Andrews, J. J. Garber, V. Yajnik, A. N. Ananthakrishnan. The impact of co‐existing immune‐mediated diseases on phenotype and outcomes in inflammatory bowel diseases. Alimentary Pharmacology & Therapeutics 2017; 45(6): 814 doi: 10.1111/apt.13940
4
Kendra J. Kamp, Manfred Stommel. Health-Related Quality of Life Among Patients With Inflammatory Bowel Disease. Gastroenterology Nursing 2021; 44(1): 21 doi: 10.1097/SGA.0000000000000491
5
Fang Xu, James M. Dahlhamer, Emily P. Terlizzi, Anne G. Wheaton, Janet B. Croft. Receipt of Preventive Care Services Among US Adults with Inflammatory Bowel Disease, 2015–2016. Digestive Diseases and Sciences 2019; 64(7): 1798 doi: 10.1007/s10620-019-05494-w
6
Fang Xu, Anne G. Wheaton, Kamil E. Barbour, Yong Liu, Kurt J. Greenlund. Trends and Outcomes of Hip Fracture Hospitalization Among Medicare Beneficiaries with Inflammatory Bowel Disease, 2000–2017. Digestive Diseases and Sciences 2021; 66(6): 1818 doi: 10.1007/s10620-020-06476-z
7
Hubert Zatorski, Maciej Sałaga, Jakub Fichna. Role of glucagon-like peptides in inflammatory bowel diseases—current knowledge and future perspectives. Naunyn-Schmiedeberg's Archives of Pharmacology 2019; 392(11): 1321 doi: 10.1007/s00210-019-01698-z
8
Adrian L Lopresti. The Problem of Curcumin and Its Bioavailability: Could Its Gastrointestinal Influence Contribute to Its Overall Health-Enhancing Effects?. Advances in Nutrition 2018; 9(1): 41 doi: 10.1093/advances/nmx011
9
Mohamed A. Morsy, Hanaa M. Khalaf, Rehab A. Rifaai, Asmaa M.A. Bayoumi, Esraa M.M.A. Khalifa, Yasmine F. Ibrahim. Canagliflozin, an SGLT-2 inhibitor, ameliorates acetic acid-induced colitis in rats through targeting glucose metabolism and inhibiting NOX2. Biomedicine & Pharmacotherapy 2021; 141: 111902 doi: 10.1016/j.biopha.2021.111902
10
Walter Reinisch, Krisztina Gecse, Jonas Halfvarson, Peter M Irving, Jørgen Jahnsen, Laurent Peyrin-Biroulet, Gerhard Rogler, Stefan Schreiber, Silvio Danese. Clinical Practice of Adalimumab and Infliximab Biosimilar Treatment in Adult Patients With Crohn’s Disease. Inflammatory Bowel Diseases 2021; 27(1): 106 doi: 10.1093/ibd/izaa078
11
Joana Costa Antunes, Catarina Leal Seabra, Joana Margarida Domingues, Marta Oliveira Teixeira, Cláudia Nunes, Sofia Antunes Costa-Lima, Natália Cândido Homem, Salette Reis, Maria Teresa Pessoa Amorim, Helena Prado Felgueiras. Drug Targeting of Inflammatory Bowel Diseases by Biomolecules. Nanomaterials 2021; 11(8): 2035 doi: 10.3390/nano11082035
12
Anna Campanati, Andrea Marani, Emanuela Martina, Federico Diotallevi, Giulia Radi, Annamaria Offidani. Psoriasis as an Immune-Mediated and Inflammatory Systemic Disease: From Pathophysiology to Novel Therapeutic Approaches. Biomedicines 2021; 9(11): 1511 doi: 10.3390/biomedicines9111511
13
Li Wu, Zhijie Lv, Linjing Lai, Penglei Zhou. Assessment of influencing factors of hospitalization expenses for Crohn's disease patients: Based on LASSO and linear mixed model. Frontiers in Public Health 2022; 10 doi: 10.3389/fpubh.2022.925616
14
Christa Meisinger, Dennis Freuer. Rheumatoid arthritis and inflammatory bowel disease: A bidirectional two-sample Mendelian randomization study. Seminars in Arthritis and Rheumatism 2022; 55: 151992 doi: 10.1016/j.semarthrit.2022.151992
15
Akbar K. Waljee, Mohamed Noureldin, Jeffrey A. Berinstein, Shirley A. Cohen-Mekelburg, Beth I. Wallace, Kelly C. Cushing, David A. Hanauer, Toby P. Keeney-Bonthrone, Brahmajee Nallamothu, Peter D.R. Higgins. Mapping the relationships between inflammatory bowel disease and comorbid diagnoses to identify disease associations. European Journal of Gastroenterology & Hepatology 2020; 32(10): 1341 doi: 10.1097/MEG.0000000000001869
16
Kelly A. Baker, Timothy D. Miller, Frank E. Marino, Tegan E. Hartmann, Krzysztof Durkalec-Michalski. The exercise-induced inflammatory response in inflammatory bowel disease: A systematic review and meta-analysis. PLOS ONE 2022; 17(2): e0262534 doi: 10.1371/journal.pone.0262534
17
Benjamin Click, David G. Binion, Alyce M. Anderson. Predicting Costs of Care for Patients With Inflammatory Bowel Diseases. Clinical Gastroenterology and Hepatology 2017; 15(3): 393 doi: 10.1016/j.cgh.2016.11.027
18
David T. Okou, Subra Kugathasan. Role of Genetics in Pediatric Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2014; 20(10): 1878 doi: 10.1097/MIB.0000000000000085
19
Bana Hadid, Weston Buehring, Angelo Mannino, Miriam D. Weisberg, Ivan J Golub, Mitchell K Ng, Afshin E. Razi. Crohn's Disease Increases In-Hospital Lengths of Stay, Medical Complications, and Costs of Care following Primary Total Knee Arthroplasty. The Journal of Knee Surgery 2023; 36(05): 524 doi: 10.1055/s-0041-1739199
20
Lukasz S. Wylezinski, Jamieson D. Gray, Julia B. Polk, Andrew J. Harmata, Charles F. Spurlock. Illuminating an Invisible Epidemic: A Systemic Review of the Clinical and Economic Benefits of Early Diagnosis and Treatment in Inflammatory Disease and Related Syndromes. Journal of Clinical Medicine 2019; 8(4): 493 doi: 10.3390/jcm8040493
21
Jesus E. Juarez, Tahmineh Romero, Constantine A. Mantz, Abigail Pepin, Nima Aghdam, Simeng Suy, Michael L. Steinberg, Rebecca G. Levin-Epstein, Nicholas G. Nickols, Irving D. Kaplan, Robert M. Meier, Huong T. Pham, Patrick W. Linson, Robert L. Hong, Mark K. Buyyounouski, Hilary P. Bagshaw, Donald B. Fuller, Alan J. Katz, Andrew Loblaw, Sean P. Collins, Amar U. Kishan. Toxicity After Stereotactic Body Radiation Therapy for Prostate Cancer in Patients With Inflammatory Bowel Disease: A Multi-institutional Matched Case-Control Series. Advances in Radiation Oncology 2021; 6(6): 100759 doi: 10.1016/j.adro.2021.100759
22
Arnold N Forlemu, Raissa Nana Sede Mbakop , Shehroz Aslam, Zaid Ansari, Indu Srinivasan, Keng-Yu Chuang. Effect of Comorbidities on Inflammatory Bowel Disease-Related Colorectal Cancer: A Nationwide Inpatient Review. Cureus 2022;  doi: 10.7759/cureus.27599
23
Takahiro Nagata, Sadahiro Funakoshi, Daisuke Morihara, Satoshi Shakado, Keiji Yokoyama, Kazuhide Takata, Takashi Tanaka, Atsushi Fukunaga, Ryo Yamauchi, Hiromi Fukuda, Hiroki Matsuoka, So Imakiire, Hideto Sakisaka, Satoshi Matsuoka, Nobuaki Kuno, Koichi Abe, Hideki Ishibashi, Shinya Ashizuka, Fumihito Hirai. Malnutrition and inflammation status in nonobese patients with inflammatory bowel disease are associated with nonalcoholic fatty liver disease: a retrospective study. Intestinal Research 2023; 21(4): 471 doi: 10.5217/ir.2023.00035
24
Pardhu B Neelam, Alka Sharma, Vishal Sharma. Sarcopenia and frailty in inflammatory bowel disease: Emerging concepts and evidence. JGH Open 2024; 8(1) doi: 10.1002/jgh3.13033
25
Motasem Alkhayyat, Mohammad Abureesh, Arshpal Gill, George Khoudari, Mohannad Abou Saleh, Emad Mansoor, Miguel Regueiro. Lower Rates of Colorectal Cancer in Patients With Inflammatory Bowel Disease Using Anti-TNF Therapy. Inflammatory Bowel Diseases 2021; 27(7): 1052 doi: 10.1093/ibd/izaa252
26
Jihye Park, Hyuk Yoon, Cheol Min Shin, Young Soo Park, Nayoung Kim, Dong Ho Lee, Alaa El-Hussuna. Clinical factors to predict flare-up in patients with inflammatory bowel disease during international air travel: A prospective study. PLOS ONE 2022; 17(1): e0262571 doi: 10.1371/journal.pone.0262571
27
Juan Carlos Rodriguez-Duque, José Luis Calleja, Paula Iruzubieta, Marta Hernández-Conde, Coral Rivas-Rivas, María Isabel Vera, Maria Jose Garcia, Marta Pascual, Beatriz Castro, Agustín García-Blanco, Enrique García-Nieto, Soraya Curiel-del Olmo, María Luisa Cagigal, Lorena Lopez-Montejo, Tatiana Fernández-Lamas, Laura Rasines, José Ignacio Fortea, José Pedro Vaque, Yza Frias, Montserrat Rivero, María Teresa Arias-Loste, Javier Crespo. Increased risk of MAFLD and Liver Fibrosis in Inflammatory Bowel Disease Independent of Classic Metabolic Risk Factors. Clinical Gastroenterology and Hepatology 2023; 21(2): 406 doi: 10.1016/j.cgh.2022.01.039
28
Motasem Alkhayyat, Mohammad Abureesh, Ashraf Almomani, Mohannad Abou Saleh, Mohammad Zmaili, Sara El Ouali, Emad Mansoor, Alberto Rubio-Tapia, Miguel Regueiro. Patients With Inflammatory Bowel Disease on Treatment Have Lower Rates of Celiac Disease. Inflammatory Bowel Diseases 2022; 28(3): 385 doi: 10.1093/ibd/izab084
29
Tessa E. H. Römkens, Rene te Morsche, Wilbert Peters, David M. Burger, Frank Hoentjen, Joost P. H. Drenth. Urinalysis of MMX‐mesalazine as a tool to monitor 5‐ASA adherence in daily IBD practice. British Journal of Clinical Pharmacology 2018; 84(3): 477 doi: 10.1111/bcp.13462
30
Paulina Nuñez, Sandra García Mateo, Rodrigo Quera, Fernando Gomollón. La enfermedad inflamatoria intestinal y los riesgos de enfermedad cardiovascular. Gastroenterología y Hepatología 2021; 44(3): 236 doi: 10.1016/j.gastrohep.2020.09.002
31
Jiayu Ye, Natasha Haskey, Hansika Dadlani, Hatem Zubaidi, Jacqueline A. Barnett, Sanjoy Ghosh, Deanna L. Gibson. Deletion of mucin 2 induces colitis with concomitant metabolic abnormalities in mice. American Journal of Physiology-Gastrointestinal and Liver Physiology 2021; 320(5): G791 doi: 10.1152/ajpgi.00277.2020
32
Craig Barnes, Binam Bajracharya, Matthew Cannalte, Zakir Gowani, Will Haley, Taha Kass-Hout, Kyle Hernandez, Michael Ingram, Hara Prasad Juvvala, Gina Kuffel, Plamen Martinov, J Montgomery Maxwell, John McCann, Ankit Malhotra, Noah Metoki-Shlubsky, Chris Meyer, Andre Paredes, Jawad Qureshi, Xenia Ritter, Philip Schumm, Mingfei Shao, Urvi Sheth, Trevar Simmons, Alexander VanTol, Zhenyu Zhang, Robert L Grossman. The Biomedical Research Hub: a federated platform for patient research data. Journal of the American Medical Informatics Association 2022; 29(4): 619 doi: 10.1093/jamia/ocab247
33
Hubert Zatorski, Maciej Salaga, Marta Zielińska, Anna Mokrowiecka, Damian Jacenik, Wanda Małgorzata Krajewska, Ewa Małecka-Panas, Jakub Fichna. Colonic inflammation induces changes in glucose levels through modulation of incretin system. Pharmacological Reports 2021; 73(6): 1670 doi: 10.1007/s43440-021-00327-y
34
Benjamin Click, Claudia Ramos Rivers, Ioannis E. Koutroubakis, Dmitriy Babichenko, Alyce M. Anderson, Jana G. Hashash, Michael A. Dunn, Marc Schwartz, Jason Swoger, Leonard Baidoo, Arthur Barrie, Miguel Regueiro, David G. Binion. Demographic and Clinical Predictors of High Healthcare Use in Patients with Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2016; 22(6): 1442 doi: 10.1097/MIB.0000000000000763
35
Paola Conigliaro, Maria Sole Chimenti, Marta Ascolani, Paola Triggianese, Lucia Novelli, Sara Onali, Elisabetta Lolli, Emma Calabrese, Carmelina Petruzziello, Francesco Pallone, Roberto Perricone, Livia Biancone. Impact of a multidisciplinary approach in enteropathic spondyloarthritis patients. Autoimmunity Reviews 2016; 15(2): 184 doi: 10.1016/j.autrev.2015.11.002
36
Yanni Fan, Ling Zhang, Monik C Jiménez, Rhonda L Bohn, Jennifer S Thompson, Kimberly G Brodovicz, Stephani Gray, Gil Y Melmed. Economic burden related to fistulas or strictures among commercially insured patients with Crohn’s disease in the United States. Journal of Managed Care & Specialty Pharmacy 2023; 29(4): 400 doi: 10.18553/jmcp.2023.29.4.400
37
K T Park, Richard B Colletti, David T Rubin, Bal K Sharma, Amy Thompson, Andrew Krueger. Health Insurance Paid Costs and Drivers of Costs for Patients With Crohn’s Disease in the United States. American Journal of Gastroenterology 2016; 111(1): 15 doi: 10.1038/ajg.2015.207
38
Min-Kyung Joo, Jae-Won Lee, Jeong-Hwa Woo, Hyo-Jong Kim, Dong-Hyun Kim, Jung-Hye Choi. Regulation of colonic neuropeptide Y expression by the gut microbiome in patients with ulcerative colitis and its association with anxiety- and depression-like behavior in mice. Gut Microbes 2024; 16(1) doi: 10.1080/19490976.2024.2319844
39
Ji Yeon Noh, Naser Farhataziz, Michael T. Kinter, Xin Yan, Yuxiang Sun. Colonic Dysregulation of Major Metabolic Pathways in Experimental Ulcerative Colitis. Metabolites 2024; 14(4): 194 doi: 10.3390/metabo14040194
40
Maria Izabel Siqueira de ANDRADE, Regiane MAIO, Keila Fernandes DOURADO, Patrícia Fortes Cavalcanti de MACÊDO, Augusto César BARRETO NETO. EXCESSIVE WEIGHT – MUSCLE DEPLETION PARADOX AND CARDIOVASCULAR RISK FACTORS IN OUTPATIENTS WITH INFLAMMATORY BOWEL DISEASE. Arquivos de Gastroenterologia 2015; 52(1): 37 doi: 10.1590/S0004-28032015000100009
41
Fang Xu, James M. Dahlhamer, Emily P. Zammitti, Anne G. Wheaton, Janet B. Croft. Health-Risk Behaviors and Chronic Conditions Among Adults with Inflammatory Bowel Disease — United States, 2015 and 2016. MMWR. Morbidity and Mortality Weekly Report 2018; 67(6): 190 doi: 10.15585/mmwr.mm6706a4
42
Che-Yung Chao, Robert Battat, Alex Al Khoury, Sophie Restellini, Giada Sebastiani, Talat Bessissow. Co-existence of non-alcoholic fatty liver disease and inflammatory bowel disease: A review article. World Journal of Gastroenterology 2016; 22(34): 7727-7734 doi: 10.3748/wjg.v22.i34.7727
43
Ignacio Marin-Jimenez, Guillermo Bastida, Ana Forés, Esther Garcia-Planella, Federico Argüelles-Arias, Pilar Sarasa, Ignacio Tagarro, Alonso Fernández-Nistal, Carmen Montoto, Mariam Aguas, Javier Santos-Fernández, Marta Maia Bosca-Watts, Rocio Ferreiro, Olga Merino, Xavier Aldeguer, Xavier Cortés, Beatriz Sicilia, Francisco Mesonero, Manuel Barreiro-de Acosta. Impact of comorbidities on anti-TNFα response and relapse in patients with inflammatory bowel disease: the VERNE study. BMJ Open Gastroenterology 2020; 7(1): e000351 doi: 10.1136/bmjgast-2019-000351
44
Talat Bessissow, Ngoc Han Le, Kathleen Rollet, Waqqas Afif, Alain Bitton, Giada Sebastiani. Incidence and Predictors of Nonalcoholic Fatty Liver Disease by Serum Biomarkers in Patients with Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2016; 22(8): 1937 doi: 10.1097/MIB.0000000000000832
45
Steven J Edwards, Samantha Barton, Mariana Bacelar, Charlotta Karner, Peter Cain, Victoria Wakefield, Gemma Marceniuk. Prognostic tools for identification of high risk in people with Crohn’s disease: systematic review and cost-effectiveness study. Health Technology Assessment 2021; 25(23): 1 doi: 10.3310/hta25230
46
Marco Vincenzo Lenti, Alessandro Armuzzi, Fabiana Castiglione, Massimo Claudio Fantini, Gionata Fiorino, Ambrogio Orlando, Daniela Pugliese, Fernando Rizzello, Maurizio Vecchi, Antonio Di Sabatino. Are we choosing wisely for inflammatory bowel disease care? The IG-IBD choosing wisely campaign. Digestive and Liver Disease 2020; 52(1): 44 doi: 10.1016/j.dld.2019.09.019
47
Anne Bozon, Stéphane Nancey, Mélanie Serrero, Ludovic Caillo, Cyrielle Gilletta, Alban Benezech, Roman Combes, Guillaume Danan, Sandrine Akouete, Laurence Pages, Jean-François Bourgaux, Guillaume Le Cosquer, Lucile Boivineau, Magdalena Meszaros, Romain Altwegg. Risk of infection in elderly patients with inflammatory bowel disease under biologics: A prospective, multicenter, observational, one-year follow-up comparative study. Clinics and Research in Hepatology and Gastroenterology 2023; 47(5): 102107 doi: 10.1016/j.clinre.2023.102107
48
Irēna Teterina, Viktorija Mokricka, Eva Petrošina, Juris Pokrotnieks. Burden of extraintestinal manifestations and comorbidities in treated and untreated ulcerative colitis and Crohn’s disease: a Latvian nationwide prescription database study 2014–2019. Proceedings of the Latvian Academy of Sciences. Section B. Natural, Exact, and Applied Sciences. 2022; 76(5-6): 608 doi: 10.2478/prolas-2022-0094
49
Reinier Cornelis Anthonius van Linschoten, Anouk Sjoukje Huberts, Nikki van Leeuwen, Jan Antonius Hazelzet, Janneke van der Woude, Rachel Louise West, Desirée van Noord, V. de Jonge, F. H. J. Wolfhagen, A. G. L. Bodelier, J. Hoekstra, C. J. van der Woude, A. C. de Vries, R. L. West, D. van Noord, R. C. A. van Linschoten, E. Visser, K. E. Verweij, F. J. G. M. Kubben, I.L. Holster, C. E. Fitzpatrick, K. Robbers, H. G. Vermeulen, S. K. van der Wiel, S. V. Jansen. Validity of the self-administered comorbidity questionnaire in patients with inflammatory bowel disease. Therapeutic Advances in Gastroenterology 2023; 16 doi: 10.1177/17562848231202159
50
Webber Chan, Viraj C. Kariyawasam, Shin Kim, Aviv V. Pudipeddi, Sudarshan Paramsothy, Hang Hock Shim, Fadi H. Mourad, Nik Ding, Marc Ferrante, Rupert W. Leong. Gastroenterologists’ preference and risk perception on the use of immunomodulators and biological therapies in elderly patients with ulcerative colitis: an international survey. European Journal of Gastroenterology & Hepatology 2020; 32(8): 976 doi: 10.1097/MEG.0000000000001768
51
Gretchen A Lam, Hala Albarrak, Cassidy J McColl, Alaina Pizarro, Harsha Sanaka, Adrian Gomez-Nguyen, Fabio Cominelli, Andre Paes Batista da Silva. The Oral-Gut Axis: Periodontal Diseases and Gastrointestinal Disorders. Inflammatory Bowel Diseases 2023; 29(7): 1153 doi: 10.1093/ibd/izac241
52
Chang-Kee Hyun. Molecular and Pathophysiological Links between Metabolic Disorders and Inflammatory Bowel Diseases. International Journal of Molecular Sciences 2021; 22(17): 9139 doi: 10.3390/ijms22179139
53
Pablo A. Olivera, Axel Dignass, Marla C. Dubinsky, Giovanni Peretto, Paulo G. Kotze, Iris Dotan, Taku Kobayashi, Subrata Ghosh, Fernando Magro, Jose Rocha Faria-Neto, Britta Siegmund, Silvio Danese, Laurent Peyrin-Biroulet. Preventing and managing cardiovascular events in patients with inflammatory bowel diseases treated with small-molecule drugs, an international Delphi consensus. Digestive and Liver Disease 2024; 56(8): 1270 doi: 10.1016/j.dld.2024.03.010
54
Camilo Obando, Zhijie Ding, Erik Muser, Neel Vaidya, Wenqin Qiang, Xiaoxi Sun, Huiqi Wang, Rajesh Mallampati, Lin Xie. Persistence, Dose Titration, and Health Care Resource Utilization Among Crohn’s Disease Patients Treated With Ustekinumab: A Real-World Analysis in the United States. Advances in Therapy 2020; 37(5): 2127 doi: 10.1007/s12325-020-01276-3
55
Fang Xu, Yong Liu, Anne G. Wheaton, Kristina M. Rabarison, Janet B. Croft. Trends and Factors Associated with Hospitalization Costs for Inflammatory Bowel Disease in the United States. Applied Health Economics and Health Policy 2019; 17(1): 77 doi: 10.1007/s40258-018-0432-4
56
Carlos Augusto Real Martinez, José Aires Pereira, Julia Soto Rizzato, Gabriele Polezi, Roberto de Paula do Nascimento, Mario Roberto Marostica Junior. Natural Plant Products in Inflammatory Bowel Diseases. 2023; : 415 doi: 10.1016/B978-0-323-99111-7.00016-7
57
Paulina Nuñez, Sandra García Mateo, Rodrigo Quera, Fernando Gomollón. Inflammatory bowel disease and the risk of cardiovascular diseases. Gastroenterología y Hepatología (English Edition) 2021; 44(3): 236 doi: 10.1016/j.gastre.2021.02.003
58
Angel Li, Matthew Coote, Lena Thin. Prevalence and risk factors for early medical and surgical complications following an admission for acute severe ulcerative colitis. Therapeutic Advances in Gastroenterology 2023; 16 doi: 10.1177/17562848231215148
59
Viraj C Kariyawasam, Shin Kim, Fadi H Mourad, Christian P Selinger, Peter H Katelaris, D Brian Jones, Charles McDonald, Gavin Barr, Grace Chapman, James Colliwshaw, Paul C Lunney, Kate Middleton, Rosy R Wang, Tony Huang, Jane Andrews, Priyanthi W Pathirana, Rupert W Leong. Comorbidities Rather Than Age Are Associated With the Use of Immunomodulators in Elderly-onset Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2019; 25(8): 1390 doi: 10.1093/ibd/izy389
60
Eleonora Scaioli, Andrea Belluzzi, Luigi Ricciardiello, Daniele Del Rio, Enrica Rotondo, Pedro Mena, Eleonora Derlindati, Francesca Danesi. Pomegranate juice to reduce fecal calprotectin levels in inflammatory bowel disease patients with a high risk of clinical relapse: Study protocol for a randomized controlled trial. Trials 2019; 20(1) doi: 10.1186/s13063-019-3321-8
61
Charles N. Bernstein, Zoann Nugent, Seth Shaffer, Harminder Singh, Ruth Ann Marrie. Comorbidity before and after a diagnosis of inflammatory bowel disease. Alimentary Pharmacology & Therapeutics 2021; 54(5): 637 doi: 10.1111/apt.16444
62
Marla C Dubinsky, Raymond K Cross, William J Sandborn, Millie Long, Xue Song, Nianwen Shi, Yao Ding, Samantha Eichner, Brandee Pappalardo, Arijit Ganguli, Anthony Wang. Extraintestinal Manifestations in Vedolizumab and Anti-TNF-Treated Patients With Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2018; 24(9): 1876 doi: 10.1093/ibd/izy065
63
Petra Černá, Scott Kilpatrick, Danielle A Gunn-Moore. Feline comorbidities: What do we really know about feline triaditis?. Journal of Feline Medicine and Surgery 2020; 22(11): 1047 doi: 10.1177/1098612X20965831
64
Åsa H Everhov, Hamed Khalili, Johan Askling, Pär Myrelid, Jonas F Ludvigsson, Jonas Halfvarson, Caroline Nordenvall, Martin Neovius, Jonas Söderling, Ola Olén. Work Loss Before and After Diagnosis of Crohn’s Disease. Inflammatory Bowel Diseases 2019; 25(7): 1237 doi: 10.1093/ibd/izy382
65
Ashwin N. Ananthakrishnan, Tamara Donaldson, Karen Lasch, Vijay Yajnik. Management of Inflammatory Bowel Disease in the Elderly Patient. Inflammatory Bowel Diseases 2017; 23(6): 882 doi: 10.1097/MIB.0000000000001099
66
Martha Bayliss, Regina Rendas-Baum, Michelle K White, Mark Maruish, Jakob Bjorner, Sandra L Tunis. Health-related quality of life (HRQL) for individuals with self-reported chronic physical and/or mental health conditions: panel survey of an adult sample in the United States. Health and Quality of Life Outcomes 2012; 10(1) doi: 10.1186/1477-7525-10-154
67
Wolf-Henning Boehncke. Systemic Inflammation and Cardiovascular Comorbidity in Psoriasis Patients: Causes and Consequences. Frontiers in Immunology 2018; 9 doi: 10.3389/fimmu.2018.00579
68
Jami Kinnucan, David Binion, Raymond Cross, Elisabeth Evans, Kevin Harlen, Laura Matarese, Amy Mullins, Bud O’Neal, Marci Reiss, Frank I. Scott, Alandra Weaver, Jonathan Rosenberg. Inflammatory Bowel Disease Care Referral Pathway. Gastroenterology 2019; 157(1): 242 doi: 10.1053/j.gastro.2019.03.064
69
Aristo Vojdani, Elroy Vojdani, Martha Herbert, Datis Kharrazian. Correlation between Antibodies to Bacterial Lipopolysaccharides and Barrier Proteins in Sera Positive for ASCA and ANCA. International Journal of Molecular Sciences 2020; 21(4): 1381 doi: 10.3390/ijms21041381
70
Ben Wilkinson, Leanne Trick, Annie Knight, Vincent Valton, James Goodhand, Nick A. Kennedy, Neel Heerasing, Tariq Ahmad, Amy Bland, Rebecca Elliott, Jonathan P. Roiser, Chris Dickens. Factors associated with depression in people with inflammatory bowel disease: The relationship between active disease and biases in neurocognitive processing. Neurogastroenterology & Motility 2019; 31(8) doi: 10.1111/nmo.13647
71
Seymour Katz, Yingheng Liu. Geriatric Gastroenterology. 2021; : 1675 doi: 10.1007/978-3-030-30192-7_66
72
Nashwa Eltantawy, Islam Abd El-Hamid El-Zayyadi, Ahmed A. Elberry, Layla M. Salah, Mohamed E. A. Abdelrahim, Amira B. Kassem. Association of genetic polymorphism of NUDT15, TPMT and ITPA gene in the toxicity and efficacy of azathioprine-based regimen in Egyptian inflammatory bowel disease patients. Beni-Suef University Journal of Basic and Applied Sciences 2023; 12(1) doi: 10.1186/s43088-023-00340-5
73
Hanna Öhlmann, Laura Ricarda Lanters, Nina Theysohn, Jost Langhorst, Harald Engler, Adriane Icenhour, Sigrid Elsenbruch. Distinct Alterations in Central Pain Processing of Visceral and Somatic Pain in Quiescent Ulcerative Colitis Compared to Irritable Bowel Syndrome and Health. Journal of Crohn's and Colitis 2023; 17(10): 1639 doi: 10.1093/ecco-jcc/jjad080
74
Jordana L. Sommer, Renée El-Gabalawy, Natalie Mota. Understanding the association between posttraumatic stress disorder characteristics and physical health conditions: A population-based study. Journal of Psychosomatic Research 2019; 126: 109776 doi: 10.1016/j.jpsychores.2019.109776
75
Seymour Katz, Yingheng Liu. Geriatric Gastroenterology. 2020; : 1 doi: 10.1007/978-3-319-90761-1_66-1
76
Helga Radner. Multimorbidity in rheumatic conditions. Wiener klinische Wochenschrift 2016; 128(21-22): 786 doi: 10.1007/s00508-016-1090-x
77
Marjorie Argollo, Daniela Gilardi, Carina Peyrin-Biroulet, Jean-Francois Chabot, Laurent Peyrin-Biroulet, Silvio Danese. Comorbidities in inflammatory bowel disease: a call for action. The Lancet Gastroenterology & Hepatology 2019; 4(8): 643 doi: 10.1016/S2468-1253(19)30173-6
78
Sofie Ronja Petersen, Nathalie Fogh Rasmussen, Agnete Overgaard Donskov, Lau Caspar Thygesen, Kim Rose Olsen, Linda Juel Ahrenfeldt, Vibeke Andersen. Socioeconomic equality in initiation of biologic treatment in Danish patients with inflammatory bowel disease. Wiener klinische Wochenschrift 2024;  doi: 10.1007/s00508-024-02376-8
79
Ashish R Srinivasan. Treat to target in Crohn’s disease: A practical guide for clinicians. World Journal of Gastroenterology 2024; 30(1): 50-69 doi: 10.3748/wjg.v30.i1.50
Write to the Help Desk
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345